AV
Atlas Venture Opportunity Fund I, LP
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Atlas Venture Opportunity Fund I, LP. Insider active across 2 companies, notably Dyne Therapeutics, Inc.. In total, 15 filings have been logged. History available since 17 June 2026. The latest transaction was filed on 7 July 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is free.
Declarations15 total
60,858 shares@ US$22.840.035% mcap37.6% of flowCommonSEC144:0001628280-26-047534
100,019 shares@ US$23.070.059% mcap62.4% of flowCommonSEC144:0001628280-26-047358
40,702 shares@ US$20.940.022% mcap14.5% of flowCommonSEC144:0001628280-26-046093
10,473 shares@ US$108.120.012% mcap14.4% of flowCommon StockSEC144:0001628280-26-046098
57,451 shares@ US$116.460.069% mcap85.6% of flowCommon StockSEC144:0001628280-26-045807
64,411 shares@ US$20.610.035% mcap22.7% of flowCommonSEC144:0001628280-26-045818
67,329 shares@ US$99.87Common StockSEC144:0001628280-26-045610
5,019 shares@ US$20.33CommonSEC144:0001628280-26-045612
16,542 shares@ US$98.25Common StockSEC144:0001628280-26-045289
19,973 shares@ US$20.26CommonSEC144:0001628280-26-045294
173 shares@ US$99.45Common StockSEC144:0001628280-26-044985
30,774 shares@ US$20.87CommonSEC144:0001628280-26-044988
34,152 shares@ US$90.43Common StockSEC144:0001628280-26-044732
14,128 shares@ US$89.90Common StockSEC144:0001628280-26-044426
12,902 shares@ US$87.44Common StockSEC144:0001628280-26-044012
About Atlas Venture Opportunity Fund I, LP
Atlas Venture Opportunity Fund I, LP is a shareholder of Dyne Therapeutics, Inc. and Kymera Therapeutics, Inc. It has 6 filings in total. Across the 6 recent filings tracked, all are sales, totaling EUR 12026653, over the period from 2026-06-26 to 2026-07-07, mainly notices of proposed sale (Form 144).